About Globin Solutions
Globin Solutions is a company based in Pittsburgh (United States) founded in 2017. Globin Solutions has raised $5 million across 2 funding rounds from investors including UPMC, HHS and TusPark. Globin Solutions offers products and services including Antidotal Therapies. Globin Solutions operates in a competitive market with competitors including GSK, eGenesis, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
- Headquarter Pittsburgh, United States
- SectorsHealthcare
- Email••••••••
- Website globinsolutions.com
- Social LinkedIn X Facebook
- Legal Name Globin Solutions, Inc.
- Total Equity Funding$5 M (USD)
in 2 rounds
- Latest Funding Round$1.73 M (USD), Grant
Feb 2020
- InvestorsUPMC
& 2 more
Products & Services of Globin Solutions
Globin Solutions offers a comprehensive portfolio of products and services, including Antidotal Therapies.
Develops treatments for human poisonings using globin chemistry.
Funding Insights of Globin Solutions
Globin Solutions has successfully raised a total of $5M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1.73 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.0M
- Total Rounds 2
- Last Round Grant — $1.7M
- First Round $5.0M
(Jan 2018)
- Investors Count 3
All 2 funding rounds of Globin Solutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Globin Solutions
Globin Solutions has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include UPMC, HHS and TusPark.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
TusPark is operated as a science park and innovation ecosystem facilitator. | – | tuspark.co.uk | United Kingdom | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Multispecialty hospitals are operated as a nationwide chain. | 1986 | upmc.com | United States |
Investor details for Globin Solutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Globin Solutions
7 people are tracked at Globin Solutions (4 in leadership, 2 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Jason J. Rose | CEO | Leadership |
Xueli Wang | Chief Financial Officer | Leadership |
Jesus Tejero | Chief Scientific Officer | Leadership |
Anthony Demartino | Research Director | Leadership |
Jeanne Cunicelli | Board Member | Board & advisors |
Mark T. Gladwin | Chairman | Board & advisors |
Lindsey Bocian | Program Administrator | Team |
Complete people profiles for Globin Solutions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Globin Solutions
3 dated milestones of Globin Solutions across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Globin Solutions is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Grant, of $1.7M.
Competitors of Globin Solutions
Globin Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, eGenesis, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| egenesisbio.com | 2015 | Cambridge, United States | $481.4M | 94 | Gene transplantation platform for humanizing pig cells is developed. | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.5M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.8M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.4M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.7M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| beamtx.com | 2017 | Cambridge, United States | $222.0M | 340 | Developer of gene therapy using CRISPR base editing to treat diseases | |
| korrobio.com | 2018 | Cambridge, United States | $4.0M | 77 | RNA-editing technologies are provided for precision medicine applications. |
Detailed competitors of Globin Solutions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Globin Solutions
The website of Globin Solutions (globinsolutions.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 101.7% vs previous month
Latest news on Globin Solutions
Complete news archive for Globin Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Globin Solutions
10 companies that operate in the same segment as Globin Solutions (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Globin Solutions
Globin Solutions was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Globin Solutions is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Globin Solutions is a funded company, having raised a total of $5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Jan 2018.
Globin Solutions was founded in 2017 and is based in Pittsburgh, United States. The company operates in the biotechnology sector, focusing on antidotal therapies for human poisonings. Its technology centers on neuroglobin (Ngb), a hemoglobin-like protein present in the brain. A genetically engineered variant, Ngb H64Q, has been developed to enhance carbon monoxide scavenging capabilities.
Globin Solutions's top competitors include Sutro Biopharma, Synthego and eGenesis.
Globin Solutions offers Antidotal Therapies.
Globin Solutions operates through Globin Solutions, Inc..